Market Overview:
The global PSA test market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of prostate cancer, technological advancements in PSA testing, and rising demand for early diagnosis and treatment of prostate cancer. However, the high cost of PSA tests is expected to restrain the growth of this market during the forecast period. The global PSA test market is segmented on the basis of type, application, and region. On the basis of application, it is classified into screening applications; post-treatment monitoring applications; other diagnostic applications (prostate-specific antigen density [PSAD] measurement); and research applications. By region, it is analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U.K.), Asia Pacific (China Japan India South Korea Australia New Zealand), and Middle East & Africa (Saudi Arabia UAE Qatar South Africa).
Product Definition:
The prostate-specific antigen (PSA) test is a blood test used to screen for prostate cancer in men. PSA is a protein produced by the prostate gland. The level of PSA in the blood increases as the size of the prostate gland increases. A high level of PSA may be a sign of prostate cancer.
CLIA:
The U.S. FDA has approved the use of CEA test for prostate cancer screening, however; it is not mandatory as of now. However, many healthcare organizations are supporting its implementation and usage in PSA tests to increase their market penetration by promoting awareness about early diagnosis and treatment options available for this disease.
ELISA:
ELISA (Enzyme-Linked Immunosorbent Assay) is a test used for detecting the level of prostate-specific antigen in the blood. It also helps to identify men who may be at risk of developing PCa, or any other disease for that matter. ELISA is considered as one of the most important tests used in PSA testing market along with prostate MRI and Digital Rectal Exam (DRE).
Application Insights:
The screening application segment dominated the global PSA test market in 2017. This can be attributed to factors such as high usage rates for prostate cancer screening programs and rising awareness about early detection of the disease. For instance, according to a study published by NCBI in 2018, it was found that around 54% of men aged between 55 and 74 years had a PSA level tested during their lifetime.
In addition, key players are launching new products specifically designed for screening purposes which is further driving growth. For instance, in January 2019 Roche launched CxPlate Prostate Cancer Test with improved performance features such as faster results (20 minutes) compared to other liquid biopsies currently available in the market (2 hours).
Regional Analysis:
North America dominated the global PSA test market in 2017. The rising prevalence of prostate cancer and the presence of established healthcare facilities are some factors contributing to its growth. In addition, increasing government funding for research and development activities is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness a lucrative CAGR during the forecast period owing to an increase in disposable income, growing awareness about early diagnosis, high unmet medical needs of patients & availability & adoption of innovative technologies such as point-of-care testing platforms by manufacturers coupled with an increase in investment by governments for R&D purposes are some factors driving this regional market growth. Moreover, economic development has led to improvement in living standards which has resulted into increased consumer spending on health care services thereby fueling industry expansion over the projected time frame (2018 - 2030).
Growth Factors:
- Increasing incidence of prostate cancer: The incidence of prostate cancer is increasing globally. This will drive the demand for PSA tests as a means to detect the disease at an early stage.
- Growing awareness about PSA tests: There is growing awareness among men about the benefits of PSA testing in detecting prostate cancer at an early stage. This will help to boost demand for PSA tests in the coming years.
- Advances in diagnostic technology: Technological advances are helping to make PSA testing more accurate and efficient, thus driving its adoption among men who wish to screen for prostate cancer risk factors.
Scope Of The Report
Report Attributes
Report Details
Report Title
PSA Test Market Research Report
By Type
CLIA, ELISA, Others,
By Application
Screening, Post-treatment Monitoring, Others,
By Companies
Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch, BodiTech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global PSA Test Market Report Segments:
The global PSA Test market is segmented on the basis of:
Types
CLIA, ELISA, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Screening, Post-treatment Monitoring, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Siemens Healthcare
- DiaSorin
- Roche
- Beckman Coulter
- PerkinElmer
- Tosoh
- Ortho Clinical
- Fujirebio
- Mediwatch
- BodiTech
Highlights of The PSA Test Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CLIA
- ELISA
- Others
- By Application:
- Screening
- Post-treatment Monitoring
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the PSA Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
PSA Test is a blood test that measures the level of prostate-specific antigen (PSA). PSA levels may be elevated in men with prostate cancer.
Some of the major companies in the psa test market are Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch, BodiTech.
The psa test market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. PSA Test Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. PSA Test Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. PSA Test Market - Supply Chain
4.5. Global PSA Test Market Forecast
4.5.1. PSA Test Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. PSA Test Market Size (000 Units) and Y-o-Y Growth
4.5.3. PSA Test Market Absolute $ Opportunity
5. Global PSA Test Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. PSA Test Market Size and Volume Forecast by Type
5.3.1. CLIA
5.3.2. ELISA
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global PSA Test Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. PSA Test Market Size and Volume Forecast by Application
6.3.1. Screening
6.3.2. Post-treatment Monitoring
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global PSA Test Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. PSA Test Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global PSA Test Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. PSA Test Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global PSA Test Demand Share Forecast, 2019-2026
9. North America PSA Test Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America PSA Test Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America PSA Test Market Size and Volume Forecast by Application
9.4.1. Screening
9.4.2. Post-treatment Monitoring
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America PSA Test Market Size and Volume Forecast by Type
9.7.1. CLIA
9.7.2. ELISA
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America PSA Test Demand Share Forecast, 2019-2026
10. Latin America PSA Test Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America PSA Test Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America PSA Test Market Size and Volume Forecast by Application
10.4.1. Screening
10.4.2. Post-treatment Monitoring
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America PSA Test Market Size and Volume Forecast by Type
10.7.1. CLIA
10.7.2. ELISA
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America PSA Test Demand Share Forecast, 2019-2026
11. Europe PSA Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe PSA Test Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe PSA Test Market Size and Volume Forecast by Application
11.4.1. Screening
11.4.2. Post-treatment Monitoring
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe PSA Test Market Size and Volume Forecast by Type
11.7.1. CLIA
11.7.2. ELISA
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe PSA Test Demand Share, 2019-2026
12. Asia Pacific PSA Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific PSA Test Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific PSA Test Market Size and Volume Forecast by Application
12.4.1. Screening
12.4.2. Post-treatment Monitoring
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific PSA Test Market Size and Volume Forecast by Type
12.7.1. CLIA
12.7.2. ELISA
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific PSA Test Demand Share, 2019-2026
13. Middle East & Africa PSA Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa PSA Test Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa PSA Test Market Size and Volume Forecast by Application
13.4.1. Screening
13.4.2. Post-treatment Monitoring
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa PSA Test Market Size and Volume Forecast by Type
13.7.1. CLIA
13.7.2. ELISA
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa PSA Test Demand Share, 2019-2026
14. Competition Landscape
14.1. Global PSA Test Market: Market Share Analysis
14.2. PSA Test Distributors and Customers
14.3. PSA Test Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Siemens Healthcare
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. DiaSorin
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Roche
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Beckman Coulter
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. PerkinElmer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Tosoh
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Ortho Clinical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Fujirebio
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Mediwatch
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. BodiTech
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook